Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription

Articles published in Cardiovasc Res

Retrieve available abstracts of 93 articles:
HTML format

Single Articles

    September 2022
  1. NAH J, Shirakabe A, Mukai R, Zhai P, et al
    Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart.
    Cardiovasc Res. 2022;118:2638-2651.
    PubMed     Abstract available

  2. HUBERT F, Payan SM, Pelce E, Bouchard L, et al
    FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis.
    Cardiovasc Res. 2022;118:2625-2637.
    PubMed     Abstract available

  3. LECOUR S, Du Pre BC, Botker HE, Brundel BJJM, et al
    Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart.
    Cardiovasc Res. 2022;118:2566-2581.
    PubMed     Abstract available

  4. LIU T, Meng Z, Liu J, Li J, et al
    Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells.
    Cardiovasc Res. 2022 Sep 5. pii: 6692411. doi: 10.1093.
    PubMed     Abstract available

    August 2022
  5. ANG D, Berry C
    FAVOR III China: quantitative flow ratio-guided coronary intervention in practice.
    Cardiovasc Res. 2022;118:e78-e80.

  6. RIZZO G, Gropper J, Piollet M, Vafadarnejad E, et al
    Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction.
    Cardiovasc Res. 2022 Aug 11. pii: 6660804. doi: 10.1093.
    PubMed     Abstract available

    July 2022
  7. ZHAO T, Mallat Z
    Adapting treatments for adaptive immunity in ischaemic heart disease.
    Cardiovasc Res. 2022;118:e66-e68.

  8. WEI X, Zou S, Xie Z, Wang Z, et al
    EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization.
    Cardiovasc Res. 2022;118:2179-2195.
    PubMed     Abstract available

  9. RIOS R, Miller RJH, Hu LH, Otaki Y, et al
    Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry.
    Cardiovasc Res. 2022;118:2152-2164.
    PubMed     Abstract available

    June 2022
  10. CREA F, Liuzzo G
    Attilio Maseri: scientist, clinician, mentor, and gentleman.
    Cardiovasc Res. 2022;118:e57-e58.

  11. HARM T, Bild A, Dittrich K, Goldschmied A, et al
    Acute coronary syndrome is associated with a substantial change in the platelet lipidome.
    Cardiovasc Res. 2022;118:1904-1916.
    PubMed     Abstract available

  12. COUCH LS, Fiedler J, Chick G, Clayton R, et al
    Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure.
    Cardiovasc Res. 2022;118:1758-1770.
    PubMed     Abstract available

  13. OZCAN I, Toya T, Corban MT, Ahmad A, et al
    Circulating progenitor cells are associated with plaque progression and long-term outcomes in heart transplant patients.
    Cardiovasc Res. 2022;118:1703-1712.
    PubMed     Abstract available

  14. MARGARITIS M, Saini F, Baranowska-Clarke AA, Parsons S, et al
    Vascular histopathology and connective tissue ultrastructure in spontaneous coronary artery dissection: pathophysiological and clinical implications.
    Cardiovasc Res. 2022;118:1835-1848.
    PubMed     Abstract available

    May 2022
  15. HE W, McCarroll CS, Nather K, Ford K, et al
    Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.
    Cardiovasc Res. 2022;118:1535-1547.
    PubMed     Abstract available

    March 2022
  16. YU JK, Liang JA, Franceschi WH, Huang Q, et al
    Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Cardiovasc Res. 2022;118:1247-1261.
    PubMed     Abstract available

  17. ZENG L, Moser S, Mirza-Schreiber N, Lamina C, et al
    Cis-epistasis at the LPA locus and risk of cardiovascular diseases.
    Cardiovasc Res. 2022;118:1088-1102.
    PubMed     Abstract available

  18. SHAH M, He Z, Rauf A, Beikoghli Kalkhoran S, et al
    Extracellular histones are a target in myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2022;118:1115-1125.
    PubMed     Abstract available

    February 2022
  19. ARIBAS E, Roeters van Lennep JE, Elias-Smale SE, Piek JJ, et al
    Prevalence of microvascular angina among patients with stable symptoms in the absence of obstructive coronary artery disease: a systematic review.
    Cardiovasc Res. 2022;118:763-771.
    PubMed     Abstract available

    January 2022
  20. DEL CAMPO CV, Liaw NY, Gunadasa-Rohling M, Matthaei M, et al
    Regenerative potential of epicardium-derived extracellular vesicles mediated by conserved miRNA transfer.
    Cardiovasc Res. 2022;118:597-611.
    PubMed     Abstract available

  21. KALKHORAN SB, Kriston-Vizi J, Hernandez-Resendiz S, Crespo-Avilan GE, et al
    Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.
    Cardiovasc Res. 2022;118:282-294.
    PubMed     Abstract available

  22. ZIETZER A, Steffen E, Niepmann S, Dusing P, et al
    MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease.
    Cardiovasc Res. 2022;118:316-333.
    PubMed     Abstract available

  23. DEHGHANI T, Thai PN, Sodhi H, Ren L, et al
    Selectin-targeting glycosaminoglycan-peptide conjugate limits neutrophil-mediated cardiac reperfusion injury.
    Cardiovasc Res. 2022;118:267-281.
    PubMed     Abstract available

    December 2021
  24. PETRIE MC, Jhund PS, Connolly E, Mark PB, et al
    High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis.
    Cardiovasc Res. 2021 Dec 7. pii: 6454738. doi: 10.1093.
    PubMed     Abstract available

    November 2021
  25. OIKONOMOU EK, Antonopoulos AS, Schottlander D, Marwan M, et al
    Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device.
    Cardiovasc Res. 2021;117:2677-2690.
    PubMed     Abstract available

  26. POBER JS, Chih S, Kobashigawa J, Madsen JC, et al
    Cardiac allograft vasculopathy: current review and future research directions.
    Cardiovasc Res. 2021;117:2624-2638.
    PubMed     Abstract available

  27. HEINRICHS M, Ashour D, Siegel J, Buchner L, et al
    The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
    Cardiovasc Res. 2021;117:2664-2676.
    PubMed     Abstract available

  28. WANG Y, Polten F, Jackle F, Korf-Klingebiel M, et al
    A mouse model of cardiogenic shock.
    Cardiovasc Res. 2021;117:2414-2415.

    September 2021
  29. RAVINDRAN D, Karimi Galougahi K, Tan JTM, Kavurma MM, et al
    The multiple roles of chemokines in the mechanisms of stent biocompatibility.
    Cardiovasc Res. 2021;117:2299-2308.
    PubMed     Abstract available

    August 2021
  30. DAVIDSON SM, Padro T, Bollini S, Vilahur G, et al
    Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart.
    Cardiovasc Res. 2021;117:2161-2174.
    PubMed     Abstract available

  31. LIBERALE L, Akhmedov A, Vlachogiannis NI, Bonetti NR, et al
    Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system.
    Cardiovasc Res. 2021;117:2275-2288.
    PubMed     Abstract available

  32. PORSCH F, Mallat Z, Binder CJ
    Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies.
    Cardiovasc Res. 2021 Aug 27. pii: 6358718. doi: 10.1093.
    PubMed     Abstract available

  33. SAGRIS M, Antonopoulos AS, Theofilis P, Oikonomou E, et al
    Risk factors profile of young and older patients with Myocardial Infarction.
    Cardiovasc Res. 2021 Aug 6. pii: 6343454. doi: 10.1093.
    PubMed     Abstract available

    July 2021
  34. YANG H, Shao N, Holmstrom A, Zhao X, et al
    Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissue.
    Cardiovasc Res. 2021;117:2125-2136.
    PubMed     Abstract available

  35. BOUKENS BJD, Dacey M, Meijborg VMF, Janse MJ, et al
    Mechanism of ventricular premature beats elicited by left stellate ganglion stimulation during acute ischaemia of the anterior left ventricle.
    Cardiovasc Res. 2021;117:2083-2091.
    PubMed     Abstract available

  36. XU JY, Xiong YY, Tang RJ, Jiang WY, et al
    Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction.
    Cardiovasc Res. 2021 Jul 14. pii: 6321229. doi: 10.1093.
    PubMed     Abstract available

  37. NOSALSKI R, Guzik TJ
    IL-15 and IL-7: keys to dysregulated inflammation in acute coronary syndromes.
    Cardiovasc Res. 2021;117:1806-1808.

  38. THONDAPU V, Mamon C, Poon EKW, Kurihara O, et al
    High spatial endothelial shear stress gradient independently predicts site of acute coronary plaque rupture and erosion.
    Cardiovasc Res. 2021;117:1974-1985.
    PubMed     Abstract available

  39. BULLENKAMP J, Mengoni V, Kaur S, Chhetri I, et al
    Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome.
    Cardiovasc Res. 2021;117:1935-1948.
    PubMed     Abstract available

    June 2021
  40. MANGOLD A, Ondracek AS, Hofbauer TM, Scherz T, et al
    Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction.
    Cardiovasc Res. 2021 Jun 26. pii: 6310009. doi: 10.1093.
    PubMed     Abstract available

    May 2021
  41. FIGTREE GA, Vernon ST
    Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries.
    Cardiovasc Res. 2021;117:e76-e78.

  42. TAO Z, Loo S, Su L, Tan S, et al
    Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.
    Cardiovasc Res. 2021;117:1578-1591.
    PubMed     Abstract available

  43. MORRIS PD, Gosling R, Zwierzak I, Evans H, et al
    A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease.
    Cardiovasc Res. 2021;117:1567-1577.
    PubMed     Abstract available

    April 2021
  44. PAGANELLI F, Gaudry M, Ruf J, Guieu R, et al
    Recent advances in the role of the adenosinergic system in coronary artery disease.
    Cardiovasc Res. 2021;117:1284-1294.
    PubMed     Abstract available

  45. BOLLI R, Solankhi M, Tang XL, Kahlon A, et al
    Cell Therapy in Patients with Heart Failure: A Comprehensive Review and Emerging Concepts.
    Cardiovasc Res. 2021 Apr 19. pii: 6237881. doi: 10.1093.
    PubMed     Abstract available

  46. YU J, Li J, Leaver PJ, Arnott C, et al
    Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS Program and CREDENCE trial.
    Cardiovasc Res. 2021 Apr 7. pii: 6214523. doi: 10.1093.
    PubMed     Abstract available

    March 2021
  47. ZHAO TX, Ur-Rahman MA, Sage AP, Victor S, et al
    Rituximab in Patients with Acute ST-elevation Myocardial Infarction (RITA-MI): an Experimental Medicine Safety Study.
    Cardiovasc Res. 2021 Mar 30. pii: 6203810. doi: 10.1093.
    PubMed     Abstract available

  48. HEUSCH G, Rassaf T
    Protection from cardiotoxicity of cancer chemotherapy: a novel target for remote ischaemic conditioning?
    Cardiovasc Res. 2021;117:985-986.

  49. PRAG HA, Gruszczyk AV, Huang MM, Beach TE, et al
    Mechanism of succinate efflux upon reperfusion of the ischaemic heart.
    Cardiovasc Res. 2021;117:1188-1201.
    PubMed     Abstract available

  50. BUDOFF MJ, Muhlestein JB, Bhatt DL, Le Pa VT, et al
    Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
    Cardiovasc Res. 2021;117:1070-1077.
    PubMed     Abstract available

    February 2021
  51. TRINDER M, Zekavat SM, Uddin MM, Pampana A, et al
    Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein(a).
    Cardiovasc Res. 2021 Feb 24. pii: 6149309. doi: 10.1093.

  52. NAMBU H, Takada S, Maekawa S, Matsumoto J, et al
    Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
    Cardiovasc Res. 2021;117:805-819.
    PubMed     Abstract available

  53. KIZILAY MANCINI O, Huynh DN, Menard L, Shum-Tim D, et al
    Ex vivo Ikkbeta ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis.
    Cardiovasc Res. 2021;117:756-766.
    PubMed     Abstract available

  54. LIANG Y, Zhu J, Liu L, Anand SS, et al
    Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease.
    Cardiovasc Res. 2021;117:942-949.
    PubMed     Abstract available

  55. KOMPA AR, Greening DW, Kong AM, McMillan PJ, et al
    Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction.
    Cardiovasc Res. 2021;117:918-929.
    PubMed     Abstract available

  56. DE LUCIA C, Grisanti LA, Borghetti G, Piedepalumbo M, et al
    GRK5 contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
    Cardiovasc Res. 2021 Feb 9. pii: 6131786. doi: 10.1093.
    PubMed     Abstract available

    January 2021
  57. LECOUR S
    Remote ischaemic conditioning modulates platelet reactivity: the need to optimize the therapy is more important than ever before.
    Cardiovasc Res. 2021;117:346-347.

    Sphingosine-1-phosphate receptor-1 (S1PR1) signalling: the homeostatic pathway of the heart.
    Cardiovasc Res. 2021;117:357-359.

  59. PERRINO C, Ferdinandy P, Botker HE, Brundel BJJM, et al
    Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.
    Cardiovasc Res. 2021;117:367-385.
    PubMed     Abstract available

  60. KOAY YC, Chen YC, Wali JA, Luk AWS, et al
    Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
    Cardiovasc Res. 2021;117:435-449.
    PubMed     Abstract available

  61. GOROG DA, Farag M, Spinthakis N, Yellon DM, et al
    Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction: a substudy of the CONDI-2/ERIC-PPCI randomized controlled trial.
    Cardiovasc Res. 2021;117:623-634.
    PubMed     Abstract available

  62. KUANG Y, Li X, Liu X, Wei L, et al
    Vascular endothelial S1pr1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction.
    Cardiovasc Res. 2021;117:585-599.
    PubMed     Abstract available

  63. ANTIKAINEN AAV, Sandholm N, Tregouet DA, Charmet R, et al
    Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus.
    Cardiovasc Res. 2021;117:600-612.
    PubMed     Abstract available

  64. KAIER TE, Alaour B, Marber M
    Cardiac troponin and defining myocardial infarction.
    Cardiovasc Res. 2021 Jan 17. pii: 6103159. doi: 10.1093.
    PubMed     Abstract available

  65. FIOLET ATL, Thompson PL, Mosterd A
    Colchicine in coronary disease: another renaissance of an ancient drug.
    Cardiovasc Res. 2021;117:e4-e6.

  66. MUELLER KAL, Langnau C, Gunter M, Poschel S, et al
    Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection.
    Cardiovasc Res. 2021;117:224-239.
    PubMed     Abstract available

  67. MAIN A, Robertson-Gray O, Fuller W
    Cyclophilin D palmitoylation and permeability transition: a new twist in the tale of myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2021;117:15-17.

  68. AMANAKIS G, Sun J, Fergusson MM, McGinty S, et al
    Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
    Cardiovasc Res. 2021;117:212-223.
    PubMed     Abstract available

  69. CORCORAN D, Radjenovic A, Mordi IR, Nazir SA, et al
    Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial.
    Cardiovasc Res. 2021;117:320-329.
    PubMed     Abstract available

  70. LIMA CORREA B, El Harane N, Gomez I, Rachid Hocine H, et al
    Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.
    Cardiovasc Res. 2021;117:292-307.
    PubMed     Abstract available

  71. NAKASHIMA Y, Sakai Y, Mizuno Y, Furuno K, et al
    Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
    Cardiovasc Res. 2021;117:96-108.
    PubMed     Abstract available

  72. LI Y, Yan H, Guo J, Han Y, et al
    Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease.
    Cardiovasc Res. 2021;117:240-255.
    PubMed     Abstract available

    October 2020
  73. WU X, Reboll MR, Korf-Klingebiel M, Wollert KC, et al
    Angiogenesis After Acute Myocardial Infarction.
    Cardiovasc Res. 2020 Oct 16. pii: 5924555. doi: 10.1093.
    PubMed     Abstract available

    August 2020
  74. PERROTTA S, Carnevale D
    A neuro-humoral activation of RAAS in endothelial dysfunction modulating immunity in heart failure.
    Cardiovasc Res. 2020 Aug 4. pii: 5880579. doi: 10.1093.

    June 2020
  75. ANGIOLILLO DJ, Baber U, Mehran R
    Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial.
    Cardiovasc Res. 2020;116:e70-e72.

  76. LI J, Gong Y, Wang W, Yang Q, et al
    Accuracy of computational pressure-fluid dynamics applied to coronary angiography to derive fractional flow reserve: FLASH FFR.
    Cardiovasc Res. 2020;116:1349-1356.
    PubMed     Abstract available

    May 2020
  77. KAUR A, Mackin ST, Schlosser K, Wong FL, et al
    Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease.
    Cardiovasc Res. 2020;116:1113-1124.
    PubMed     Abstract available

  78. SI R, Zhang Q, Tsuji-Hosokawa A, Watanabe M, et al
    Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.
    Cardiovasc Res. 2020;116:1186-1198.
    PubMed     Abstract available

  79. HOOGENDOORN A, Kok AM, Hartman EMJ, de Nisco G, et al
    Multidirectional wall shear stress promotes advanced coronary plaque development: comparing five shear stress metrics.
    Cardiovasc Res. 2020;116:1136-1146.
    PubMed     Abstract available

  80. GOLLMANN-TEPEKOYLU C, Polzl L, Graber M, Hirsch J, et al
    miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy.
    Cardiovasc Res. 2020;116:1226-1236.
    PubMed     Abstract available

    April 2020
  81. OWENIER C, Hesse J, Alter C, Ding Z, et al
    Novel technique for the simultaneous isolation of cardiac fibroblasts and epicardial stromal cells from the infarcted murine heart.
    Cardiovasc Res. 2020;116:1047-1058.
    PubMed     Abstract available

  82. ROCZKOWSKY A, Chan BYH, Lee TYT, Mahmud Z, et al
    Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.
    Cardiovasc Res. 2020;116:1021-1031.
    PubMed     Abstract available

    March 2020
  83. BAIREY MERZ CN, Pepine CJ, Shimokawa H, Berry C, et al
    Treatment of coronary microvascular dysfunction.
    Cardiovasc Res. 2020;116:856-870.
    PubMed     Abstract available

  84. PADRO T, Manfrini O, Bugiardini R, Canty J, et al
    ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.
    Cardiovasc Res. 2020;116:741-755.
    PubMed     Abstract available

  85. WAHEED N, Elias-Smale S, Malas W, Maas AH, et al
    Sex differences in non-obstructive coronary artery disease.
    Cardiovasc Res. 2020;116:829-840.
    PubMed     Abstract available

  86. SECHTEM U, Brown D, Godo S, Lanza GA, et al
    Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease).
    Cardiovasc Res. 2020;116:771-786.
    PubMed     Abstract available

  87. ONG P, Safdar B, Seitz A, Hubert A, et al
    Diagnosis of coronary microvascular dysfunction in the clinic.
    Cardiovasc Res. 2020;116:841-855.
    PubMed     Abstract available

  88. LAKSHMANAN S, Shekar C, Kinninger A, Dahal S, et al
    Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography.
    Cardiovasc Res. 2020;116:479-482.

  89. SPADACCIO C, Antoniades C, Nenna A, Chung C, et al
    Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?
    Cardiovasc Res. 2020;116:505-519.
    PubMed     Abstract available

  90. LOU X, Zhao M, Fan C, Fast VG, et al
    N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Cardiovasc Res. 2020;116:671-685.
    PubMed     Abstract available

  91. GAO C, Wang R, Li B, Guo Y, et al
    TXNIP/Redd1 signalling and excessive autophagy: a novel mechanism of myocardial ischaemia/reperfusion injury in mice.
    Cardiovasc Res. 2020;116:645-657.
    PubMed     Abstract available

  92. BOISGUERIN P, Covinhes A, Gallot L, Barrere C, et al
    A novel therapeutic peptide targeting myocardial reperfusion injury.
    Cardiovasc Res. 2020;116:633-644.
    PubMed     Abstract available

    February 2020
  93. MOLITOR M, Rudi WS, Garlapati V, Finger S, et al
    Nox2+ Myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
    Cardiovasc Res. 2020 Feb 20. pii: 5741408. doi: 10.1093.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.